share_log

藥明合聯：董事會會議通告

WUXI XDC: NOTICE OF BOARD MEETING

HKEX ·  Mar 13 05:02
Summary by Moomoo AI
藥明合聯生物技術有限公司（「本公司」）將於2024年3月25日（星期一）召開董事會會議，主要目的是批准及發佈本集團截至2023年12月31日止年度的全年業績。會議將由執行董事兼首席執行官李錦才博士主持，並有其他執行董事、非執行董事及獨立非執行董事參與。此次會議對投資者而言意義重大，因為它將揭示公司一年來的財務表現及業務進展。
藥明合聯生物技術有限公司（「本公司」）將於2024年3月25日（星期一）召開董事會會議，主要目的是批准及發佈本集團截至2023年12月31日止年度的全年業績。會議將由執行董事兼首席執行官李錦才博士主持，並有其他執行董事、非執行董事及獨立非執行董事參與。此次會議對投資者而言意義重大，因為它將揭示公司一年來的財務表現及業務進展。
Pharmaceutical United Biotechnology Co., Ltd. (the “Company”) will hold a Board Meeting on Monday, March 25, 2024 for the primary purpose of approving and publishing the Group's annual results for the year ended December 31, 2023. The meeting will be chaired by the Executive Director and Chief Executive Officer, Dr. Lee Kam Chai, and will be attended by other Executive Directors, Non-Executive Directors and Independent Non-Executive Directors. The meeting is significant for investors as it will reveal the company's financial performance and business progress over the year.
Pharmaceutical United Biotechnology Co., Ltd. (the “Company”) will hold a Board Meeting on Monday, March 25, 2024 for the primary purpose of approving and publishing the Group's annual results for the year ended December 31, 2023. The meeting will be chaired by the Executive Director and Chief Executive Officer, Dr. Lee Kam Chai, and will be attended by other Executive Directors, Non-Executive Directors and Independent Non-Executive Directors. The meeting is significant for investors as it will reveal the company's financial performance and business progress over the year.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more